Iovance Biotherapeutics, Inc. SC 13G and SC 13G/A reports

Location
825 Industrial Road, 4 Th Floor, San Carlos, CA
State of incorporation
DE
Fiscal year end
December 31
Data updated at
11/7/2024, 05:20 PM
Form type Sec Links Description Filing date Reporting date
SC 13G/A Report Oct 18, 2024
SC 13G Report SC 13G Mar 1, 2024
SC 13G/A Report SC 13G/A Feb 14, 2024
SC 13G/A Report IOVANCE BIOTHERAPEUTICS, INC. Feb 14, 2024
SC 13G/A Report SCHEDULE 13G/A Feb 13, 2024
SC 13G/A Report SC 13G/A Feb 9, 2024
SC 13G/A Report Jan 26, 2024
SC 13G/A Report Jan 25, 2024
SC 13G Report IOVANCE BIOTHERAPEUTICS, INC. Feb 17, 2023
SC 13G/A Report SC 13G/A Feb 14, 2023
SC 13G/A Report IOVANCE BIOTHERAPEUTICS, INC. Feb 14, 2023
SC 13G/A Report SCHEDULE 13G/A Feb 9, 2023
SC 13G/A Report SEC SCHEDULE 13G Feb 6, 2023
SC 13G Report Feb 3, 2023
SC 13G Report Feb 2, 2023
SC 13G Report SC 13G Dec 30, 2022
SC 13G/A Report Feb 24, 2022
SC 13G/A Report SC 13G/A Feb 14, 2022
SC 13G/A Report Feb 14, 2022
SC 13G/A Report IOVANCE BIOTHERAPEUTICS, INC. Feb 11, 2022
SC 13G/A Report SCHEDULE 13G/A Feb 10, 2022
SC 13G Report SEC SCHEDULE 13G Feb 4, 2022
SC 13G/A Report Feb 4, 2022
SC 13G/A Report SC 13G/A Feb 16, 2021
SC 13G/A Report Feb 16, 2021
SC 13G/A Report IOVANCE BIOTHERAPEUTICS, INC. Feb 12, 2021
SC 13G/A Report SCHEDULE 13G/A Feb 10, 2021
SC 13G/A Report Feb 1, 2021
SC 13G/A Report Jan 29, 2021
SC 13G Report SC 13G Jan 11, 2021
SC 13G/A Report IOVANCE BIOTHERAPEUTICS, INC. Feb 24, 2020
SC 13G/A Report SC 13G/A Feb 14, 2020
SC 13G Report Feb 14, 2020
SC 13G/A Report IOVANCE BIOTHERAPEUTICS, INC. Feb 14, 2020
SC 13G Report SCHEDULE 13G Feb 11, 2020
SC 13G/A Report Feb 5, 2020
SC 13G/A Report Feb 4, 2020
SC 13G Report SC 13G Feb 14, 2019
SC 13G/A Report IOVANCE BIOTHERAPEUTICS, INC. Feb 14, 2019
SC 13G Report Feb 14, 2019
SC 13G/A Report Feb 13, 2019
SC 13G/A Report SCHEDULE 13G HOLDINGS REPORT AMENDMENT Feb 13, 2019
SC 13G/A Report Feb 4, 2019
SC 13G/A Report Jan 28, 2019
SC 13G/A Report AMENDMENT NO. 3 TO SCHEDULE 13G Feb 14, 2018
SC 13G Report Feb 14, 2018
SC 13G/A Report 13G/A Feb 13, 2018
SC 13G Report Feb 13, 2018
SC 13G/A Report Feb 13, 2018
SC 13G/A Report IOVANCE BIOTHERAPEUTICS, INC. Feb 12, 2018
SC 13G/A Report Feb 7, 2018
SC 13G Report Jan 25, 2018
SC 13G/A Report Aug 3, 2017
SC 13G/A Report May 9, 2017
SC 13G/A Report Feb 16, 2017
SC 13G/A Report SC 13G/A Feb 14, 2017
SC 13G/A Report Feb 14, 2017
SC 13G Report Feb 13, 2017
SC 13G Report 13G Feb 13, 2017
SC 13G/A Report Feb 10, 2017
SC 13G/A Report LION BIOTECHNOLOGIES, INC. Feb 9, 2017
SC 13G Report Feb 7, 2017
SC 13G/A Report Jan 25, 2017
SC 13G/A Report Nov 3, 2016
SC 13G/A Report SC 13G/A Feb 16, 2016
SC 13G Report VENBIO SELECT ADVISOR LLC Feb 12, 2016
SC 13G/A Report Feb 12, 2016
SC 13G Report LION BIOTECHNOLOGIES INC. Feb 12, 2016
SC 13G Report Feb 11, 2016
SC 13G/A Report AMENDMENT NO. 5 Feb 9, 2016
SC 13G Report Jan 28, 2016
SC 13G/A Report NONE May 20, 2015
SC 13G Report SCHEDULE 13G Feb 17, 2015
SC 13G/A Report Feb 13, 2015
SC 13G/A Report SCHEDULE 13D AMENDMENT Feb 11, 2015
SC 13G Report Jul 10, 2014
SC 13G/A Report AMENDMENT TO SCHEDULE 13G Feb 10, 2014
SC 13G Report SCHEDULE 13G Jan 2, 2014
SC 13G Report NONE Jun 3, 2013
SC 13G/A Report SCHEDULE 13G AMENDMENT Jun 8, 2012
SC 13G/A Report NONE Apr 4, 2012
SC 13G/A Report BRISTOL INVESTMENT FUND, LTD. Feb 15, 2012
SC 13G Report NONE Oct 21, 2011
SC 13G Report Feb 10, 2011
SC 13G Report Dec 20, 2010
SC 13G Report BRISTOL INVESTMENT FUND, LTD. Nov 5, 2010